NZ706302A - Sublingual wafer solid dosage form containing amylopectin - Google Patents
Sublingual wafer solid dosage form containing amylopectinInfo
- Publication number
- NZ706302A NZ706302A NZ706302A NZ70630213A NZ706302A NZ 706302 A NZ706302 A NZ 706302A NZ 706302 A NZ706302 A NZ 706302A NZ 70630213 A NZ70630213 A NZ 70630213A NZ 706302 A NZ706302 A NZ 706302A
- Authority
- NZ
- New Zealand
- Prior art keywords
- dosage form
- solid dosage
- form containing
- containing amylopectin
- amylopectin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012238330A AU2012238330B1 (en) | 2010-10-26 | 2012-10-11 | Fast Dissolving Solid Dosage Form |
| AU2013200684A AU2013200684B1 (en) | 2010-10-26 | 2013-02-08 | Fast Dissolving Solid Dosage Form |
| AU2013200682A AU2013200682C1 (en) | 2010-10-26 | 2013-02-08 | Fast Dissolving Solid Dosage Form |
| PCT/IB2013/002594 WO2014057351A1 (fr) | 2012-10-11 | 2013-10-11 | Forme de dosage solide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ706302A true NZ706302A (en) | 2017-07-28 |
Family
ID=50478109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ706302A NZ706302A (en) | 2012-10-11 | 2013-10-11 | Sublingual wafer solid dosage form containing amylopectin |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP2906201A4 (fr) |
| JP (1) | JP2015533155A (fr) |
| KR (1) | KR20150063567A (fr) |
| CN (2) | CN107669649A (fr) |
| CA (1) | CA2886573C (fr) |
| HK (1) | HK1208353A1 (fr) |
| IL (2) | IL238104B (fr) |
| MY (1) | MY191875A (fr) |
| NZ (1) | NZ706302A (fr) |
| SG (1) | SG11201502425WA (fr) |
| WO (1) | WO2014057351A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6217052B2 (ja) * | 2016-04-21 | 2017-10-25 | 邦赫 小牧 | 口腔清浄用発泡性錠剤 |
| US12427121B2 (en) | 2016-05-05 | 2025-09-30 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| US12433850B2 (en) | 2016-05-05 | 2025-10-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine and prodrug compositions |
| WO2017192921A1 (fr) | 2016-05-05 | 2017-11-09 | Monosol Rx, Llc | Compositions d'épinéphrine à administration améliorée |
| JP2017193547A (ja) * | 2017-05-08 | 2017-10-26 | 邦赫 小牧 | 口腔清浄用発泡性錠剤 |
| KR20200060748A (ko) * | 2017-09-27 | 2020-06-01 | 어퀘스티브 테라퓨틱스, 아이엔씨. | 강화된 전달 에프네프린 및 프로드러그 조성물 |
| EP3687509A1 (fr) * | 2017-09-27 | 2020-08-05 | Aquestive Therapeutics, Inc. | Compositions pharmaceutiques à perméation améliorée |
| IT201800003507A1 (it) * | 2018-03-13 | 2019-09-13 | Fulton Medicinali S P A | Compressa sublinguale comprendente sildenafil citrato |
| SMT202600055T1 (it) * | 2019-01-07 | 2026-03-09 | Antecip Bioventures Ii Llc | Combinazione di destrometorfano e bupropione per trattare la depressione in pazienti asiatici |
| CN109846841B (zh) * | 2019-01-18 | 2021-06-01 | 西安力邦医药科技有限责任公司 | 一种速效氯巴占口服冻干制剂及其制备方法 |
| US12589083B2 (en) * | 2019-05-07 | 2026-03-31 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
| US11382873B1 (en) * | 2021-01-08 | 2022-07-12 | Vitalis Analgesics LLC | Oral administration of ketamine |
| US12465564B2 (en) | 2021-10-25 | 2025-11-11 | Aquestive Therapeutics, Inc. | Oral and nasal compositions and methods of treatment |
| WO2025120580A1 (fr) * | 2023-12-08 | 2025-06-12 | Ix Biopharma Ltd | Compositions et méthodes pour induire une réponse immunitaire mucosale |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596298B2 (en) * | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
| US6552024B1 (en) * | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
| AU2001273545A1 (en) * | 2000-07-19 | 2002-01-30 | Lavipharm Laboratories, Inc. | Sildenafil citrate solid dispersions having high water solubility |
| US7118765B2 (en) * | 2001-12-17 | 2006-10-10 | Spi Pharma, Inc. | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
| EP2343045A3 (fr) * | 2003-02-24 | 2011-09-21 | Pharmaceutical Productions Inc. | Système d'administration de médicament par voie transmucosique |
| CA2612917A1 (fr) * | 2005-06-23 | 2007-01-04 | Schering Corporation | Formulations orales a absorption rapide d'inhibiteurs de la pde5 |
| KR100905027B1 (ko) * | 2007-10-03 | 2009-06-30 | (주)씨엘팜 | 식용 필름 |
| WO2009045022A2 (fr) * | 2007-10-03 | 2009-04-09 | C.L. Pharm | Film comestible |
| DE102008014533A1 (de) * | 2008-03-15 | 2009-09-17 | Lts Lohmann Therapie-Systeme Ag | Gingival-Wafer |
| US8623401B2 (en) * | 2008-03-27 | 2014-01-07 | Fenwafe Inc. | Wafer formulation |
| US8715715B2 (en) * | 2008-11-03 | 2014-05-06 | Nal Pharmaceuticals Ltd. | Dosage form for insertion into the mouth |
| DK2493457T3 (en) * | 2009-10-30 | 2017-10-02 | Ix Biopharma Ltd | QUICK-SOLVING SOLID DOSAGE FORM |
| CN103025321A (zh) * | 2010-03-23 | 2013-04-03 | 生物联合制药公司 | 快速溶解的药物释放系统 |
| FR2967066B1 (fr) * | 2010-11-04 | 2013-06-14 | Ethypharm Sa | Utilisation par voie sublinguale de microgranules non comprimes |
| JP5841433B2 (ja) * | 2012-01-11 | 2016-01-13 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
| AU2014233363B2 (en) * | 2013-03-15 | 2017-06-29 | EyePoint, Inc. | Compositions, formulations and methods for treating ocular diseases |
-
2013
- 2013-10-11 KR KR1020157012031A patent/KR20150063567A/ko not_active Ceased
- 2013-10-11 CA CA2886573A patent/CA2886573C/fr active Active
- 2013-10-11 WO PCT/IB2013/002594 patent/WO2014057351A1/fr not_active Ceased
- 2013-10-11 HK HK15108989.9A patent/HK1208353A1/xx unknown
- 2013-10-11 CN CN201711156600.7A patent/CN107669649A/zh active Pending
- 2013-10-11 MY MYPI2015000938A patent/MY191875A/en unknown
- 2013-10-11 CN CN201380060281.3A patent/CN104812378B/zh active Active
- 2013-10-11 EP EP13845400.4A patent/EP2906201A4/fr not_active Withdrawn
- 2013-10-11 NZ NZ706302A patent/NZ706302A/en unknown
- 2013-10-11 SG SG11201502425WA patent/SG11201502425WA/en unknown
- 2013-10-11 JP JP2015536236A patent/JP2015533155A/ja active Pending
-
2015
- 2015-04-01 IL IL238104A patent/IL238104B/en active IP Right Grant
-
2020
- 2020-03-04 IL IL273076A patent/IL273076A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150063567A (ko) | 2015-06-09 |
| IL273076A (en) | 2020-04-30 |
| MY191875A (en) | 2022-07-18 |
| IL238104B (en) | 2020-03-31 |
| EP2906201A1 (fr) | 2015-08-19 |
| EP2906201A4 (fr) | 2016-10-19 |
| SG11201502425WA (en) | 2015-05-28 |
| IL238104A0 (en) | 2015-05-31 |
| WO2014057351A1 (fr) | 2014-04-17 |
| CN107669649A (zh) | 2018-02-09 |
| CN104812378A (zh) | 2015-07-29 |
| CN104812378B (zh) | 2017-12-01 |
| CA2886573C (fr) | 2019-04-02 |
| JP2015533155A (ja) | 2015-11-19 |
| CA2886573A1 (fr) | 2014-04-17 |
| HK1208353A1 (en) | 2016-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ706302A (en) | Sublingual wafer solid dosage form containing amylopectin | |
| MY150626A (en) | Fast dissolving solid dosage form | |
| PH12013501821A1 (en) | Solid forms of 3-(5-amino-2methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses | |
| MX2015000813A (es) | Composiciones liposómicas de inhibidores de proteasoma basadas en epoxicetona. | |
| TN2010000152A1 (en) | Pharmaceutical compositions | |
| MX361413B (es) | Formas cristalinas de un macrólido y usos para las mismas. | |
| MX2013007057A (es) | Metodos para producir composiciones farmaceuticas estabilizadas de dosis solida que contienen morfinanos. | |
| MX393195B (es) | Capsula de estradiol soluble para insercion por via vaginal | |
| GT201300309A (es) | Liberación modificada de 4-metil-3-[[4-(3-piridinil)-2- pirimidinil]-amino]-n-[5-(4-metil -1h-imidazol-1-il)-3-(trifluoro-metil)-fenil]-benzamida solubilizada utilizando ácidos orgánicos | |
| MY194495A (en) | Compositions and methods for transmucosal absorption | |
| PE20140255A1 (es) | Tableta dispersable en forma oral | |
| IN2014MN02245A (fr) | ||
| PL2217219T3 (pl) | Podjęzykowa musująca tabletka progesteronu w połączeniu z cyklodekstryną | |
| EA201171497A1 (ru) | Снижение флуктуаций опиоидов в крови | |
| PH12014501288A1 (en) | Oral care compositions | |
| IN2013CH05441A (fr) | ||
| MX2015011109A (es) | Composiciones estables de activador de glucoquinasa. | |
| TN2015000135A1 (en) | Modified release formulations for oprozomib | |
| PH12014502834A1 (en) | Pharmaceutical form for extended release of active substances | |
| BR122020011180B8 (pt) | formulações injetáveis de compostos de tetraciclina | |
| PH12013501552A1 (en) | Oral care compositions | |
| AR062925A1 (es) | Metodo para fabricar tabletas que contienen agentes farmacologicamente activos | |
| CL2011000614A1 (es) | Forma de dosificacion oral solida que comprende alisquireno solo o en combinacion con otro agente activo; proceso de preparacion; y uso en el tratamiento de enfermedades tales comohipertension, angina, ateroesclerosis, entre otras. | |
| PH12014501304B1 (en) | Oral care compositions | |
| MY197454A (en) | Non-enteric pharmaceutical composition comprising crofelemer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 OCT 2019 BY WRAYS Effective date: 20180713 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 OCT 2020 BY WRAYS PTY LTD Effective date: 20190927 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 OCT 2021 BY WRAYS PTY LTD Effective date: 20200923 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 OCT 2022 BY WRAYS PTY LTD Effective date: 20210928 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 OCT 2023 BY WRAYS PTY LTD Effective date: 20220930 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 OCT 2024 BY WRAYS PTY LTD Effective date: 20230913 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 OCT 2025 BY WRAYS PTY LTD Effective date: 20240913 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 OCT 2026 BY WRAYS PTY LTD Effective date: 20250930 |